CVS Stock
CVS HEALTH CORPORATION
—
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
Valuation
P/E (trailing)9.3
Forward P/E10.7
Price / sales0.2
Price / book1.4
EPS (12 mo)$8.59
Dividend yield3.49%
Beta0.58
Financial health last 12 months
Revenue growth+6.7%
Earnings growth+2150.2%
Gross margin14.2%
Net margin+2.6%
Return on equity14.1%
Debt / equity0.75
Hover a figure for what it means.
Analyst ratings Nov 2026 · 32 analysts
Consensus: Buy
Strong buy 8Buy 20
Hold 4Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 28 | 4 | 0 | Buy |
| Oct 2026 | 28 | 4 | 0 | Buy |
| Sep 2026 | 28 | 5 | 0 | Buy |
| Aug 2026 | 28 | 5 | 0 | Buy |
Latest news
Holding UnitedHealth At $330? Its Past Falls Mostly Healed
Yahoo · 1d ago
CVS Pharmacy® names Grand Prize winners of first Home Team Heroes youth soccer contest
Yahoo · 1d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
1 of 1
moved more than expected
| Report | Expected | Actual |
|---|---|---|
| Nov 4, 2026 | ±6.9% | -11.1% |